Gamma-secretase as a pharmacological target in Alzheimer disease research: When, why and how?

被引：14

作者：

Ziani-Cherif, Chewki ^{[1
]}

Mostefa-Kara, Bachir ^{[1
]}

Brixi-Gormat, Fatima Z. ^{[1
]}

机构：

[1] Univ Abou Bekr Balkaid, Lab Catalyse & Chim Fine, Tilimsen 13000, Algeria

来源：

CURRENT PHARMACEUTICAL DESIGN | 2006年 / 12卷 / 33期

关键词：

Alzheimer disease; amyloid beta precursor protein; amyloid beta; gamma-secretase; presenilins; gamma-secretase inhibitors; non-steroidal anti-inflammatory drugs;

D O I：

10.2174/138161206778792994

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Alzheimer disease (AD) is characterized by excessive deposition of amyloid beta-peptides (A beta peptides) in the form of senile plaques as well as neurofibrillary tangles (NFTs) in the brain. In the amyloidogenic pathway, the amyloid-beta precursor protein (APP) is cleaved by beta-secretase first, followed by gamma-secretase cleavage producing therefore A beta. This review summarizes the recent findings in the AD field and focuses on the different gamma-secretase inhibitors that have been developed as a therapeutic approach toward AD.

引用

页码：4313 / 4335

页数：23

共 230 条

[51] Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1 [J].

Esler, WP ;

Kimberly, WT ;

Ostaszewski, BL ;

Diehl, TS ;

Moore, CL ;

Tsai, JY ;

Rahmati, T ;

Xia, WM ;

Selkoe, DJ ;

Wolfe, MS .

NATURE CELL BIOLOGY, 2000, 2 (07) :428-434

[52] Imaging Alzheimer disease: seeing the unseeable [J].

Evanko, D .

NATURE METHODS, 2005, 2 (07) :481-481

[53] Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons [J].

Evans, DA ;

Hebert, LE ;

Beckett, LA ;

Scherr, PA ;

Albert, MS ;

Chown, MJ ;

Pilgrim, DM ;

Taylor, JO .

ARCHIVES OF NEUROLOGY, 1997, 54 (11) :1399-1405

[54] Identification of a β-secretase activity, which truncates amyloid β-peptide after its presenilin-dependent generation [J].

Fluhrer, R ;

Multhaup, G ;

Schlicksupp, A ;

Okochi, M ;

Takeda, M ;

Lammich, S ;

Willem, M ;

Westmeyer, G ;

Bode, W ;

Walter, J ;

Haass, C .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) :5531-5538

[55] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].

FOLSTEIN, MF ;

FOLSTEIN, SE ;

MCHUGH, PR .

JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198

[56] Membrane topology and nicastrin-enhanced endoproteolysis of APH-1, a component of the γ-secretase complex [J].

Fortna, RR ;

Crystal, AS ;

Morais, VA ;

Pijak, DS ;

Lee, VMY ;

Doms, RW .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (05) :3685-3693

[57] aph-1 and pen-2 are required for notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation [J].

Francis, R ;

McGrath, G ;

Zhang, JH ;

Ruddy, DA ;

Sym, M ;

Apfeld, J ;

Nicoll, M ;

Maxwell, M ;

Hai, B ;

Ellis, MC ;

Parks, AL ;

Xu, W ;

Li, JH ;

Gurney, M ;

Myers, RL ;

Himes, CS ;

Hiebsch, R ;

Ruble, C ;

Nye, JS ;

Curtis, D .

DEVELOPMENTAL CELL, 2002, 3 (01) :85-97

[58] RISK-FACTORS FOR LATE-ONSET ALZHEIMERS-DISEASE - A POPULATION-BASED, CASE-CONTROL STUDY [J].

FRATIGLIONI, L ;

AHLBOM, A ;

VIITANEN, M ;

WINBLAD, B .

ANNALS OF NEUROLOGY, 1993, 33 (03) :258-266

[59] Biological markers and the treatment of Alzheimer's disease [J].

Galasko, D .

JOURNAL OF MOLECULAR NEUROSCIENCE, 2001, 17 (02) :119-125

[60]

Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100

← 1 2 3 4 5 6 7 8 9 10 →